(2Z)-2-(dimethylaminomethylidene)-3,4-dihydroacridin-1-one
|
|
Descriptors Computed from Structure
Canonical SMILES:
CN(C)C=C1CCC2=NC3=CC=CC=C3C=C2C1=O
Isomeric SMILES
CN(C)/C=C\1/CCC2=NC3=CC=CC=C3C=C2C1=O
InChI
InChI=1S/C16H16N2O/c1-18(2)10-12-7-8-15-13(16(12)19)9-11-5-3-4-6-14(11)17-15/h3-6,9-10H,7-8H2,1-2H3/b12-10-
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- ethyl 2-(4-methylphenyl)-5-oxidanylidene-1,2-oxazole-4-carboxylate
- ethyl (Z)-3-bromanyl-4,4,4-tris(fluoranyl)but-2-enoate
- ethyl (Z)-4,4,4-tris(chloranyl)-3-methoxy-but-2-enoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(phenylmethylidene)amino]pentanamide
- ethyl 2-(1,3-dimethyl-2-oxidanylidene-purin-6-yl)sulfanylethanoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-methoxyphenyl)methylideneamino]pentanamide
- ethyl 2-(1,3-dimethyl-2-oxidanylidene-6-sulfanylidene-purin-7-yl)ethanoate
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-methylphenyl)methylideneamino]pentanamide
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,12-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-[(E)-(4-nitrophenyl)methylideneamino]pentanamide
- 2-ethyl-3,3-dimethyl-1-oxidanylidene-4H-isoquinoline-4-carboxylic acid
